1. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma
    Raheleh Roudi et al, 2016, Tumor Biol. CrossRef
  2. Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer
    Kaile Zhang et al, 2016, IJMS CrossRef
  3. Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2
    Wensi Zhao et al, 2016 CrossRef
  4. The ALDH1+ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics
    DEJIAN LI et al, 2015 CrossRef
  5. Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3
    ZHENGYI RUAN et al, 2015 CrossRef
  6. Cancer stem cells: small subpopulation or evolving fraction?
    Heiko Enderling, 2015, Integr. Biol. CrossRef
  7. Stem cell biology in thyroid cancer: Insights for novel therapies
    Parisha Bhatia, 2014, WJSC CrossRef
  8. MicroRNAs targeting prostate cancer stem cells
    Yu-Xiang Fang et al, 2015, Exp Biol Med (Maywood) CrossRef
  9. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.
    Fanny Grillet et al, 2017, Gut CrossRef
  10. Spheres from cervical cancer cells display stemness and cancer drug resistance
    Huan Liu et al, 2016 CrossRef
  11. Lithium chloride has a biphasic effect on prostate cancer stem cells and a proportional effect on midkine levels
    Mine Erguven et al, 2016 CrossRef
  12. Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
    Brandon Bumbaca et al, 2018, Acta Pharmaceutica Sinica B CrossRef
  13. Role of Telomeric TRF2 in Orosphere Formation and CSC Phenotype Maintenance Through Efficient DNA Repair Pathway and its Correlation with Recurrence in OSCC
    Arka Saha et al, 2018, Stem Cell Rev and Rep CrossRef
  14. Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
    A N Paranjape et al, 2016, Oncogene CrossRef
  15. Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy
    Sujata Narayanan et al, 2016, Nat Rev Urol CrossRef
  16. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer
    Chantel Samardzija et al, 2015, Mol Cancer CrossRef
  17. The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH -MYCN transgenic neuroblastoma mouse model
    Jiaxiong Lu et al, 2017, Cancer Letters CrossRef
  18. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
    Martina Gruber et al, 2020, Prostate CrossRef
  19. Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
    Mannan Nouri et al, 2017, Oncotarget CrossRef
  20. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche
    Catherine A. Sánchez et al, 2016, Oncotarget CrossRef
  21. Palliative treatment efficacy of glucose inhibition combined with chemotherapy for non‑small cell lung cancer with widespread bone and brain metastases: A case report
    Yongping Liu et al, 2017, biom rep CrossRef
  22. Quantitative proteomics analysis of the role of tetraspanin-8 in the drug resistance of gastric cancer
    Lan Li et al, 2017, Int J Oncol CrossRef
  23. Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review).
    Hector Contreras Muñoz, 0 CrossRef
  24. STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population.
    Hector Contreras Muñoz, 0 CrossRef
  25. null
    Giacomo Canesin, 2020 CrossRef
  26. Designing precision medicine panels for drug refractory cancers targeting cancer STEMNESS traits
    Sudha Warrier et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  27. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
    Luciana Mosca et al, 2021, Drug Resistance Updates CrossRef
  28. Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
    Fabrizio Fontana et al, 2021, Cells CrossRef
  29. IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression
    Lina Alhaddad et al, 2021, Cancers CrossRef
  30. Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target
    Enrique A. Castellón et al, 2022, IJMS CrossRef
  31. Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC
    Rakshmitha Marni et al, 2023, Life Sciences CrossRef
  32. Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models
    Vilma Petrikaite et al, 2023, Drug Resistance Updates CrossRef
  33. Prospective pharmacological potential of cryptotanshinone in cancer therapy
    Ashif Ahamed et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef